Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis
- PMID: 38926480
- PMCID: PMC11208433
- DOI: 10.1038/s41598-024-65391-9
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis
Abstract
Classic psychedelics and MDMA have a colorful history of recreational use, and both have recently been re-evaluated as tools for the treatment of psychiatric disorders. Several studies have been carried out to assess potential long-term effects of a regular use on cognition, delivering distinct results for psychedelics and MDMA. However, to date knowledge is scarce on cognitive performance during acute effects of those substances. In this systematic review and meta-analysis, we investigate how cognitive functioning is affected by psychedelics and MDMA during the acute drug effects and the sub-acute ("afterglow") window. Our quantitative analyses suggest that acute cognitive performance is differentially affected by psychedelics when compared to MDMA: psychedelics impair attention and executive function, whereas MDMA primarily affects memory, leaving executive functions and attention unaffected. Our qualitative analyses reveal that executive functioning and creativity may be increased during a window of at least 24 h after the acute effects of psychedelics have subsided, whereas no such results have been observed for MDMA. Our findings may contribute to inform recommendations on harm reduction for recreational settings and to help fostering differential approaches for the use of psychedelics and MDMA within a therapeutic framework.
Keywords: Acute; Afterglow; Cognition; MDMA; Psychedelic; Subacute.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May;9(5):490-499. doi: 10.1016/j.bpsc.2024.02.001. Epub 2024 Feb 9. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38341085 Review.
-
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.J Psychopharmacol. 2022 Oct;36(10):1100-1117. doi: 10.1177/02698811221116926. Epub 2022 Aug 26. J Psychopharmacol. 2022. PMID: 36017784 Free PMC article. Review.
-
MDMA use and neurocognition: a meta-analytic review.Psychopharmacology (Berl). 2007 Jan;189(4):531-7. doi: 10.1007/s00213-006-0601-2. Epub 2006 Nov 3. Psychopharmacology (Berl). 2007. PMID: 17082969 Review.
-
Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.Psychopharmacology (Berl). 2004 May;173(3-4):405-10. doi: 10.1007/s00213-003-1561-4. Epub 2003 Aug 30. Psychopharmacology (Berl). 2004. PMID: 12955295
-
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.Psychopharmacology (Berl). 1998 Oct;139(3):261-8. doi: 10.1007/s002130050714. Psychopharmacology (Berl). 1998. PMID: 9784083
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical